au.\*:("ROVEI V")
Results 1 to 25 of 26
Selection :
QUANTITATIVE DETERMINATION OF NAPROXEN IN PLASMA BY A SIMPLE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHODBROQUAIRE M; ROVEI V; BRAITHWAITE R et al.1981; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1981; VOL. 224; NO 1; PP. 43-49; BIBL. 12 REF.Article
SIMPLE, SENSITIVE AND SPECIFIC GAS CHROMATOGRAPHIC METHOD FOR THE QUANTIFICATION OF DILTIAZEM IN HUMAN BODY FLUIDS.ROVEI V; MITCHARD M; MORSELLI PL et al.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 138; NO 2; PP. 391-398; BIBL. 12 REF.Article
DETERMINATION OF ANTRAFENINE AND ITS MAIN ACID METABOLITE, 2-(T-7-(TRIFLUOROMETHYL)-4-QUINOLINYL) AMINO) BENZOIC ACID, IN BIOLOGICAL FLUIDS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH LARGE VOLUME AUTOMATIC INJECTION AND GAS-LIQUID CHROMATOGRAPHY WITH DERIVATIVE FORMATIONGUINEBAULT PR; BROQUAIRE M; SANJUAN M et al.1981; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1981; VOL. 223; NO 1; PP. 103-110; BIBL. 7 REF.Article
PROCEDE DE CHROMATOGRAPHIE EN PHASE GAZEUSE POUR LA DETERMINATION DE LA NOMIFENSINE DANS LE PLASME HUMAINVERECZKEY L; BIANCHETTI G; ROVEI V et al.1976; ; S.L.; DA. 1976; PP. 1-7; DE L'ANGL.: JOURNAL OF CHROMATOGRAPHY, 1976; 116, 451-456, 4 FIG., 2 TABLMiscellaneous
IDENTIFICATION OF CYCLOBENZAPRINE-10,11-EPOXIDE AND OTHER METABOLITES AFTER INCUBATION OF CYCLOBENZAPRINE WITH RAT LIVER MICROSOMES.BELVEDERE G; ROVEI V; PANTAROTTO C et al.1975; XENOBIOTICA; G.B.; DA. 1975; VOL. 5; NO 12; PP. 765-771; BIBL. 5 REF.Article
GAS CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF NOMIFENSINE IN HUMAN PLASMA.VERECZKEY L; BIANCHETTI G; ROVEI V et al.1976; J. CHROMATOGR.; NETHERL.; DA. 1976; VOL. 116; NO 2; PP. 451-456; BIBL. 6 REF.Article
Reversed-phase high-performance liquid chromatographic separation of 14C-labelled toloxatone and its metabolitesVAJTA, S; LE MOING, J. P; ROVEI, V et al.Journal of chromatography. 1984, Vol 311, Num 2, pp 329-337, issn 0021-9673Article
PHARMACOCINETIQUE COMPAREE DE L'ANTRAFENINE CHEZ LE SUJET SAIN ET CHEZ L'INSUFFISANT RENALROVEI V; LEROY A; SAUVANET JP et al.1981; THERAPIE; ISSN 0040-5957; FRA; DA. 1981; VOL. 36; NO 1; PP. 21-26; ABS. ENG; BIBL. 13 REF.Article
SURVEILLANCE DES TAUX PLASMATIQUES DE PSYCHOTROPES CHEZ L'ENFANT. II: TAUX PLASMATIQUES D'ANTIDEPRESSEURSDUGAS M; ZARIFIAN E; LE HEURZEY MF et al.1982; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1982; VOL. 11; NO 30; PP. 2275-2279; ABS. ENG; BIBL. 18 REF.Article
PHARMACOKINETICS AND METABOLISM OF DILTIAZEM IN MANROVEI V; GOMENI R; MITCHARD M et al.1980; ACTA CARDIOL.; BEL; DA. 1980; VOL. 35; NO 1; PP. 35-45; ABS. FRE; BIBL. 17 REF.Article
PRELIMINARY OBSERVATIONS OF THE SIGNIFICANCE OF MONITORING TRICYCLIC ANTIDEPRESSANT PLASMA LEVELS IN THE PEDIATRIC PATIENTDUGAS M; ZARIFIAN E; LEHEUZEY MF et al.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 4; PP. 307-314; BIBL. 42 REF.Article
PHARMACOCINETIQUE DE L'ANTRAFENINE APRES PRISE UNIQUE CHEZ L'ADULTE JEUNEROVEI V; BROQUAIRE M; TEDESCHI G et al.1980; THERAPIE; ISSN 0040-5957; FRA; DA. 1980; VOL. 35; NO 4; PP. 551-552; BIBL. 6 REF.Article
MASS SPECTROMETRIC IDENTIFICATION OF 10,11-DIHYDRO-10,11-DIHYDROXYPROTRIPTYLINE IN RAT URINE AFTER ADMINISTRATION OF PROTRIPTYLINE.BELVEDERE G; FRIGERIO A; PANTAROTTO C et al.1975; FARMACO, ED. SCI.; ITAL.; DA. 1975; VOL. 30; NO 11; PP. 904-911; ABS. ANGL.; BIBL. 6 REF.Article
High-performance liquid chromatographic determination of cimoxatone and its O-demethyl metabolite in plasmaROVEI, V; RIGAL, M; SANJUAN, M et al.Journal of chromatography. 1983, Vol 277, pp 391-395, issn 0021-9673Article
Estimation of the elimination half-life of the monoamine oxidase inhibitor cimoxatone in rat brain on the basis of ex vivo inhibition dataFOWLER, C. J; STROLIN BENEDETTI, M; ROVEI, V et al.European journal of drug metabolism and pharmacokinetics. 1983, Vol 8, Num 4, pp 389-393, issn 0378-7966Article
COMPARISON OF SINGLE-DOSE PHARMACOKINETICS OF IMIPRAMINE AND MAPROTILINE IN THE ELDERLYHRDINA PD; ROVEI V; HENRY JF et al.1980; PSYCHOPHARMACOLOGY; DEU; DA. 1980; VOL. 70; NO 1; PP. 29-34; BIBL. 21 REF.Article
EFFECTS COMPARES DE L'ANTRAFENINE, DE L'ASPIRINE ET D'UN PLACEBO SUR LES PERTES SANGUINES DIGESTIVES MESUREES PAR LA METHODE DES HEMATIES MARQUEES AU CHROMEBONN RL; MARTIN BK; GORDON A et al.1980; THERAPIE; ISSN 0040-5957; FRA; DA. 1980; VOL. 35; NO 6; PP. 685-691; ABS. ENG; BIBL. 27 REF.Article
PHARMACOCINETIQUE DE L'ANTRAFENINE APRES ADMINISTRATION UNIQUE ET APRES PRISE REPETEE CHEZ LE SUJET AGESAUVANET JP; ROVEI V; GUINEBAULT P et al.1980; THERAPIE; ISSN 0040-5957; FRA; DA. 1980; VOL. 35; NO 4; PP. 552-554; BIBL. 5 REF.Article
Determination of low plasma concentrations of 3-methoxy-4-hydroxyphenylethylene glycol using gas chromatography-negative-ion chemical ionization mass spectrometryVAJTA, S; LE MOING, J. P; ROVEI, V et al.Journal of chromatography. 1985, Vol 343, Num 2, pp 239-247, issn 0021-9673Article
Pharmacokinetic and relative bioavailability studies of cimoxatone in humansROVEI, V; MITCHARD, M; STROLIN BENEDETTI, M et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 1, pp 56-62, issn 0174-4879Article
The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosisROVEI, V; ESCOURROU, J; CAMPISTRON, G et al.European journal of clinical pharmacology. 1988, Vol 35, Num 4, pp 391-396, issn 0031-6970Article
Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiencyROVEI, V; CAMPISTRON, G; DUEYMES, J.-M et al.European journal of clinical pharmacology. 1987, Vol 33, Num 3, pp 303-310, issn 0031-6970Article
Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjectsPROVOST, J.-C; FUNCK-BRENTANO, C; ROVEI, V et al.Clinical pharmacology and therapeutics. 1992, Vol 52, Num 4, pp 384-393, issn 0009-9236Article
Pharmacokinetics of dextromoramide in surgical patientsPAGANI, I; BARZAGHI, N; CREMA, F et al.Fundamental & clinical pharmacology. 1989, Vol 3, Num 1, pp 27-35, issn 0767-3981Article
